Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 6

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 6
---
 |  16 |
| Proposal                                                                                                          
 No. 2 - The Reverse Stock Split Proposal                                                                          |  22 |
| Proposal                                                                                                          
 No. 3 - Plan Amendment Proposal                                                                                   |  31 |
| Proposal                                                                                                          
 No. 4 - Share Increase Proposal                                                                                   |  43 |
| Proposal                                                                                                          
 No. 5 - The Adjournment Proposal                                                                                  |  46 |
| Other Matters                                                                                                     |  47 |
| Stockholder Communications to the Board                                                                           |  47 |
| Stockholder                                                                                                       
 Proposals and Nominations for Director                                                                            |  47 |
| Annex                                                                                                             
 A - Certificate of Amendment of Amended and Restated Certificate of Incorporation of Petros Pharmaceuticals, Inc. | A-1 |
| Annex B - Third Amendment to Amended and Restated Petros Pharmaceuticals,                                         
 Inc. 2020 Omnibus Incentive Compensation Plan                                                                     | B-1 |
| Annex C - Amended and Restated 2020 Omnibus Incentive Compensation Plan                                           | C-1 |
| Annex D - First Amendment to Amended and Restated Petros Pharmaceuticals,                                         
 Inc. 2020 Omnibus Incentive Compensation Plan                                                                     | D-1 |
| Annex E - Second Amendment to Amended and Restated Petros Pharmaceuticals,                                        
 Inc. 2020 Omnibus Incentive Compensation Plan                                                                     | E-1 |
| Annex F - Certificate of Amendment of Certificate of Incorporation of                                             
 Petros Pharmaceuticals, Inc.                                                                                      | F-1 |

<div align='center'>i

Petros Pharmaceuticals, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, NY 10036

PROXY STATEMENT FOR THE
PETROS PHARMACEUTICALS, INC.
2025 SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON APRIL 10, 2025</div>

This Proxy Statement, along
with the Notice of Special Meeting of Stockholders, contains information about the 2025 Special Meeting of Petros Pharmaceuticals, Inc.,
including any adjournments or postponements thereof. We are holding the Special Meeting at 10 a.m. Eastern Time, on Thursday, April 10,
2025, in virtual format at www.virtualshareholdermeeting.com/PTPI2025SM.

In this Proxy Statement,
we refer to Petros Pharmaceuticals, Inc. as “Petros,” “the Company,” “